Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.14M | 10.72M | 11.96M | 13.26M | 15.15M |
| Total Other Revenue | -- | -- | -- | -- | 0.00 |
| Total Revenue | 11.14M | 10.72M | 11.96M | 13.26M | 15.15M |
| Cost of Revenue | 6.03M | 6.16M | 6.39M | 6.24M | 6.71M |
| Gross Profit | 5.11M | 4.55M | 5.58M | 7.01M | 8.44M |
| SG&A Expenses | 6.50M | 6.42M | 6.39M | 6.35M | 6.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.24M | 14.30M | 14.42M | 14.26M | 14.60M |
| Operating Income | -3.10M | -3.58M | -2.46M | -1.01M | 552.30K |
| Income Before Tax | -3.58M | -4.18M | -3.13M | -1.68M | -127.50K |
| Income Tax Expenses | -40.50K | -40.50K | -40.50K | -40.50K | 110.40K |
| Earnings from Continuing Operations | -3.54 | -4.14 | -3.09 | -1.64 | -0.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.54M | -4.14M | -3.09M | -1.64M | -237.90K |
| EBIT | -3.10M | -3.58M | -2.46M | -1.01M | 552.30K |
| EBITDA | -1.89M | -2.40M | -1.31M | 194.00K | 1.54M |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 551.50M | 554.52M | 555.70M | 551.56M | 555.65M |
| Average Diluted Shares Outstanding | 551.56M | 554.60M | 556.50M | 552.99M | 557.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |